WVE
Wave Life Sciences Ltd.
$6.24
-0.14 (-2.19%)
At close · Jul 8
Market Cap
$1.20B
Shares
192,353,438
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.24
Open$6.31
Day$6.20–6.40
52W$5.02–21.73
Avg vol 30d3.3M
Short int18.2M · 9.4% float · 5.6d
Short vol57%
Last earningsApr 28, 2026
DataJan 2020–Jul 2026
Filing10-Q · Apr 28
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−36%
below
Price vs 50-day avg
−2%
below
RSI (14)
53
neutral
MACD trend
Positive
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−56%
trailing
YTD return
−63%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
4 of 233 funds reported for Jun 30 · net +942 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.44% of float · ▼ -2.0% MoM · 5.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
233 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+149%
Y/Y
EPS growth
−73%
Y/Y
Free cash flow
$-188.2M
Balance sheet
$602.1M
net cash
Quant / Vol
risk profile
Volatility
169%
annualized · 1-yr
Max drawdown
−73%
past year
ATR
5.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Jul 19, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 28, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−36%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
4 of 233 funds reported for Jun 30 · net +942 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.44% of float · ▼ -2.0% MoM · 5.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
233 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $5
Now $6 · 7%
52-wk high $22
vs 200-day avg -36%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WVE
this stock
Wave Life Sciences Ltd.
|
$1.20B | -63.3% | +149.4% | — | 9.4% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WVE | +7.4% | +9.5% | -56.1% | +7.4% | -63.3% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +7.6% | +8.6% | -63.6% | +7.6% | -72.6% |